Vera Therapeutics names Michael Morrissey Ph.D. as Board Chair; von Emster resigns

Vera Therapeutics, Inc.

Kurt von Emster resigns as director and Chair effective at 2022 annual meeting; no dispute.
Michael Morrissey appointed to Board, becomes Chair, Class II director, term through 2023 annual meeting.
Morrissey receives option grant of 40,000 shares (vs. standard 19,850) vesting over 3 years.
Cash retainers: $65k as Chair, $7.5k on Audit Committee, $4k on Nominating Committee, pro-rated for 2022.
Morrissey also appointed to Audit and Nominating Committees, effective annual meeting date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Kurt von Emster

Director and Chair

VERA · Vera Therapeutics, Inc.

Successor: Michael M. Morrissey, Ph.D.
Filed: April 12, 2022, 7:59 PM ET

Kurt von Emster notified the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) of his resignation as a director of the Company and as Chair of the Board, effective on the date of the Company’s 2022 Annual Meeting of Stockholders.

Appointed

Michael M. Morrissey, Ph.D.

Chair of the Board and Director

VERA · Vera Therapeutics, Inc.

Filed: April 12, 2022, 7:59 PM ET

the Board appointed Michael M. Morrissey, Ph.D., to the Board, to fill the vacancy resulting from Mr. von Emster’s resignation, and to serve as Chair of the Board, effective on the Annual Meeting Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kurt von Emster resigned as Director and Chair at Vera Therapeutics, Inc..

Action: resigned
Role: Director and Chair

Exact text from the filing

Kurt von Emster notified the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) of his resignation as a director of the Company and as Chair of the Board, effective on the date of the Company’s 2022 Annual Meeting of Stockholders.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael M. Morrissey, Ph.D. was appointed as Chair of the Board and Director at Vera Therapeutics, Inc..

Action: appointed
Role: Chair of the Board and Director

Exact text from the filing

the Board appointed Michael M. Morrissey, Ph.D., to the Board, to fill the vacancy resulting from Mr. von Emster’s resignation, and to serve as Chair of the Board, effective on the Annual Meeting Date.

View on SEC.gov

Vera Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-102911

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.